The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Brain Neoplasms

This is a "connection" page, showing publications Kenneth S. Cohen has written about Brain Neoplasms.
Connection Strength

2.942
  1. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model. Clin Cancer Res. 2013 Sep 01; 19(17):4553-8.
    View in: PubMed
    Score: 0.291
  2. Is low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors. CNS Oncol. 2013 May; 2(3):211-3.
    View in: PubMed
    Score: 0.286
  3. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
    View in: PubMed
    Score: 0.246
  4. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2023 04 01; 41(10):1921-1932.
    View in: PubMed
    Score: 0.140
  5. Pediatric glial tumors. Curr Treat Options Oncol. 2001 Dec; 2(6):529-36.
    View in: PubMed
    Score: 0.130
  6. Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg. 2001 May; 34(5):229-34.
    View in: PubMed
    Score: 0.125
  7. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
    View in: PubMed
    Score: 0.120
  8. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
    View in: PubMed
    Score: 0.098
  9. A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation. Cancer. 2017 Jan 01; 123(1):161-168.
    View in: PubMed
    Score: 0.090
  10. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy. Childs Nerv Syst. 2016 Aug; 32(8):1425-30.
    View in: PubMed
    Score: 0.088
  11. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50.
    View in: PubMed
    Score: 0.087
  12. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol. 2014 Aug; 38(8):1058-70.
    View in: PubMed
    Score: 0.078
  13. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol. 2014 Oct; 16(10):1408-16.
    View in: PubMed
    Score: 0.077
  14. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet. 2014 May; 46(5):462-6.
    View in: PubMed
    Score: 0.076
  15. Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade? Pediatr Blood Cancer. 2013 Dec; 60(12):2036-41.
    View in: PubMed
    Score: 0.073
  16. Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013 Mar; 15(3):360-9.
    View in: PubMed
    Score: 0.070
  17. Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young children. Pediatr Blood Cancer. 2012 Aug; 59(2):216-20.
    View in: PubMed
    Score: 0.067
  18. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol. 2010 Dec; 34(12):1783-91.
    View in: PubMed
    Score: 0.061
  19. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. J Neurooncol. 2010 Sep; 99(2):155-63.
    View in: PubMed
    Score: 0.059
  20. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23.
    View in: PubMed
    Score: 0.058
  21. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas? Pediatr Blood Cancer. 2010 Apr; 54(4):641-3.
    View in: PubMed
    Score: 0.058
  22. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug; 99(1):65-71.
    View in: PubMed
    Score: 0.057
  23. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009 Jan 20; 27(3):385-9.
    View in: PubMed
    Score: 0.053
  24. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008 Aug; 51(2):245-50.
    View in: PubMed
    Score: 0.052
  25. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer. 2007 Dec 01; 110(11):2535-41.
    View in: PubMed
    Score: 0.049
  26. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007 Jan; 11(1):83-95.
    View in: PubMed
    Score: 0.046
  27. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res. 2006 Sep 15; 66(18):9054-64.
    View in: PubMed
    Score: 0.045
  28. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006 Feb; 23(2):99-107.
    View in: PubMed
    Score: 0.043
  29. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3):198-203.
    View in: PubMed
    Score: 0.035
  30. No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
    View in: PubMed
    Score: 0.029
  31. Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol. 2000 Jul-Aug; 3(4):346-52.
    View in: PubMed
    Score: 0.029
  32. Pathology of diencephalic astrocytomas. Pediatr Neurosurg. 2000 Apr; 32(4):214-9.
    View in: PubMed
    Score: 0.029
  33. Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clin Cancer Res. 2019 12 15; 25(24):7303-7311.
    View in: PubMed
    Score: 0.028
  34. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
    View in: PubMed
    Score: 0.025
  35. Association of Neuronal Injury in the Genu and Body of Corpus Callosum After Cranial Irradiation in Children With Impaired Cognitive Control: A Prospective Study. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1234-1242.
    View in: PubMed
    Score: 0.025
  36. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res. 2011 Jun 01; 17(11):3590-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.